Statera BioPharma (STU:7CB) Short-Term Debt : €6.46 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Short-Term Debt?

Statera BioPharma's Short-Term Debt for the quarter that ended in Sep. 2022 was €6.46 Mil.

Statera BioPharma's quarterly Short-Term Debt increased from Mar. 2022 (€5.35 Mil) to Jun. 2022 (€6.05 Mil) and increased from Jun. 2022 (€6.05 Mil) to Sep. 2022 (€6.46 Mil).

Statera BioPharma's annual Short-Term Debt declined from Dec. 2019 (€1.63 Mil) to Dec. 2020 (€1.56 Mil) but then increased from Dec. 2020 (€1.56 Mil) to Dec. 2021 (€4.05 Mil).

Statera BioPharma Short-Term Debt Historical Data

The historical data trend for Statera BioPharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Short-Term Debt Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Short-Term Debt

1.63

1.56

4.05

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Short-Term Debt	Get a 7-Day Free Trial						2.45	4.05	5.35	6.05	6.46

Statera BioPharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Statera BioPharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines